<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><description>让药物创造变得容易！我们致力于成为中国健康产业的传播者、服务者、推动者。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 18 Feb 2021 17:00:46 +0800</pubDate><image><url>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</url><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>2021，研发人靠什么“牛”转乾坤？6顶思维帽必不可少</title><link>https://mp.weixin.qq.com/s/QN1WR5TqEWVVrXUce4N5WQ</link><description></description><content:encoded><![CDATA[2021，研发人靠什么“牛”转乾坤？6顶思维帽必不可少]]></content:encoded><pubDate>Thu, 18 Feb 2021 16:58:09 +0800</pubDate></item><item><title>减肥药市场难突破？GLP-1 或成新选择</title><link>https://mp.weixin.qq.com/s/DbLp4HVZ0yxSRXeKa63jJw</link><description></description><content:encoded><![CDATA[减肥药市场难突破？GLP-1 或成新选择]]></content:encoded><pubDate>Thu, 18 Feb 2021 16:58:09 +0800</pubDate></item><item><title>医药代表的朋友圈：你以为医生会看？</title><link>https://mp.weixin.qq.com/s/x-h-GF_GiPbl_FXOEywerg</link><description></description><content:encoded><![CDATA[医药代表的朋友圈：你以为医生会看？]]></content:encoded><pubDate>Thu, 18 Feb 2021 16:58:09 +0800</pubDate></item><item><title>开工大吉</title><link>https://mp.weixin.qq.com/s/EfAaluHWIgpAekyuWH17OA</link><description></description><content:encoded><![CDATA[开工大吉]]></content:encoded><pubDate>Thu, 18 Feb 2021 16:58:09 +0800</pubDate></item><item><title>0到1000亿市值，他如何打造「口腔医疗帝国」</title><link>https://mp.weixin.qq.com/s/YVCIoY8rDPf9n5nxsM1IDw</link><description></description><content:encoded><![CDATA[0到1000亿市值，他如何打造「口腔医疗帝国」]]></content:encoded><pubDate>Wed, 17 Feb 2021 10:09:32 +0800</pubDate></item><item><title>国内NDA阶段的2款自研3代EGFR-TKI，未来是否可期？</title><link>https://mp.weixin.qq.com/s/mc28j536cVePtXR5cGURLA</link><description></description><content:encoded><![CDATA[国内NDA阶段的2款自研3代EGFR-TKI，未来是否可期？]]></content:encoded><pubDate>Tue, 16 Feb 2021 11:09:48 +0800</pubDate></item><item><title>老鸟分享：CMO(首席医学官)是个啥职位？</title><link>https://mp.weixin.qq.com/s/_q1On3uvYWblYI_CbitCkA</link><description></description><content:encoded><![CDATA[老鸟分享：CMO(首席医学官)是个啥职位？]]></content:encoded><pubDate>Mon, 15 Feb 2021 09:57:28 +0800</pubDate></item><item><title>百亿HER2单抗市场，曲妥珠单抗生物类似药是否能迎来春天？</title><link>https://mp.weixin.qq.com/s/nZrrDiIWQTiNPvTRKjmoTA</link><description></description><content:encoded><![CDATA[百亿HER2单抗市场，曲妥珠单抗生物类似药是否能迎来春天？]]></content:encoded><pubDate>Sun, 14 Feb 2021 10:06:11 +0800</pubDate></item><item><title>JAK-STAT发现30年：8款产品已上市，国内赛道恒瑞、信达…已布局</title><link>https://mp.weixin.qq.com/s/BwkSPO3Q3_NYZtoXEmnJnA</link><description></description><content:encoded><![CDATA[JAK-STAT发现30年：8款产品已上市，国内赛道恒瑞、信达…已布局]]></content:encoded><pubDate>Sat, 13 Feb 2021 10:27:07 +0800</pubDate></item><item><title>大年初一 ，开门迎喜 ，药智网携全体员工给您拜年啦~祝大家牛转钱坤，大吉大利！</title><link>https://mp.weixin.qq.com/s/RTUvavVtH9eSycVsYbVK2A</link><description></description><content:encoded><![CDATA[大年初一 ，开门迎喜 ，药智网携全体员工给您拜年啦~祝大家牛转钱坤，大吉大利！]]></content:encoded><pubDate>Fri, 12 Feb 2021 00:00:29 +0800</pubDate></item><item><title>分享图片</title><link>https://mp.weixin.qq.com/s/uJiSolDrgpLfnt_Q9wp-3Q</link><description></description><content:encoded><![CDATA[分享图片]]></content:encoded><pubDate>Thu, 11 Feb 2021 08:12:52 +0800</pubDate></item><item><title>深度长文：生物制剂管线全解析！</title><link>https://mp.weixin.qq.com/s/krdhmVFJnMcl5Cl_dg7AEQ</link><description></description><content:encoded><![CDATA[深度长文：生物制剂管线全解析！]]></content:encoded><pubDate>Wed, 10 Feb 2021 09:51:11 +0800</pubDate></item><item><title>2020年CRO平均净利润行业第一，业绩下降的仅三家，最高跌幅达968%</title><link>https://mp.weixin.qq.com/s/4eaSVQ9EQLUKc8fNp2DEXQ</link><description></description><content:encoded><![CDATA[2020年CRO平均净利润行业第一，业绩下降的仅三家，最高跌幅达968%]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:24:57 +0800</pubDate></item></channel></rss>